Work

KRAS mutations in colorectal cancer patients receiving trifluridine/tipiracil plus bevacizumab: something to consider

Year: 2025

Type: article

Source: ESMO Open

DOI: 10.1016/j.esmoop.2025.105900

Authors: A. Rizzo, O. Brunetti, G. Brandi

Institutions: Istituto Tumori Bari, University of Bologna

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

OpenAlex ID: W4416275634

FWCI:

Cites: 3

Cited by:

Related to: